All In MedTech

FDA Clearance Tracker · P100045-S006

CARDIOMEMS

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Apr 29, 2016 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Apr 29, 2016

Approved

Time to decision

252 days

Received Aug 21, 2015. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P100045-S006
Device name
CARDIOMEMS
Applicant location
Atlanta, GA
Received
Aug 21, 2015
Decided
Apr 29, 2016
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P100045

Device type

Device class
Class III
Specialty
Cardiology

Every decision under product code MOM

FDA's approval statement

As written in FDA's record.

Approval for a manufacturing site located at St. Jude Medical, 2305 Walnut Street, Roseville, Minnesota, 55113, for rework/relabeling of 12 class III devices.

Source documents

Other decisions for ABBOTT MEDICAL

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.